MNV-201 is Minovia’s second generation mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with ...
Press releaseLIfT BioSciences gains access to half a million allogeneic donors through collaboration with Gift of Life Biologics Access to ...
Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does ...
News Medical on MSN1d
HLA-DRB1 molecule offers potential target for CAR therapy in relapsed acute myeloid leukemia post-transplantationOne main goal of anti-cancer therapies is to kill tumor cells without affecting the surrounding normal cells. Therefore, many ...
A research team has identified the impact of stem cell infusion timing on the incidence and severity of acute ...
A research team led by Prof. ZHAN Cheng from the University of Science and Technology of China (USTC), and Chief Physician ZHU Xiaoyu from the First Affiliated Hospital of USTC has identified how stem ...
A team of scientists led by Northwestern Medicine investigators have uncovered new details about a deadly heart condition ...
Researchers sought to determine whether patients with T-ALL would be responsive to salvage therapy with homoharringtonine, cytarabine, and aclarubicin.
Monzr M. Al Malki, MD, discussed data for AlloHeme, a blood test used to detect risk of relapse post-transplant in patients ...
IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback